Purpose To evaluate whether anti-vascular endothelial growth factor (VEGF) therapy
combined with panretinal photocoagulation could reverse diabetic retinopathy (DR). Method …

Purpose To identify optical coherence tomography angiography (OCTA)–derived vessel
metrics of the macula and optic nerve head (ONH) that predict diabetic retinopathy (DR) …

Background: High-risk proliferative diabetic retinopathy (HR-PDR) is the advanced stage of
diabetic retinopathy progression with poor prior treatment efficacy and high rates of …

Purpose To compare the disease characteristics and treatment outcomes of patients with
neovascular glaucoma (NVG) presenting with visual acuity (VA) 6/60 or better in two …

Objective: To compare efficacy of intravitreal bevacizumab augmented with Panretinal
photocoagulation versus Panretinal photocoagulation alone in high risk proliferative diabetic …

A core obstacle to neovascular glaucoma (NVG) management and academic discussion is
that it is a multidisciplinary problem where the etiology of anterior-segment …

Objective: The objective of the study was to investigate the effectiveness of aflibercept and
panretinal photocoagulation (PRP) in the treatment of proliferative diabetic retinopathy …

Background/Aims. This study evaluates changes of flow and structure of diabetic retinal
neovascularization (NV) treated with intravitreal antivascular endothelial growth factor …

Neovascular glaucoma most commonly occurs after development of proliferative diabetic
retinopathy. Proliferative diabetic retinopathy occurs in approximately 7% of patients with …

The diagnosis and management of NVG have substantial room for improvement. Current
challenges to NVG care include standardization of the definition and staging of NVG, earlier …